Silence Therapeutics PLC(SLN) - 2021 Q2 - Earnings Call Transcript

Silence Therapeutics plc (NASDAQ:SLN) Q2 2021 Earnings Conference Call August 12, 2021 8:00 AM ET Company Participants Gem Hopkins - Head, Investor Relations and Corporate Communications Mark Rothera - President and CEO Craig Tooman - Chief Financial Officer Giles Campion - EVP, Head of R&D and CMO Conference Call Participants Thomas Shrader - BTIG Patrick Trucchio - H.C. Wainwright Myles Minter - William Blair Operator Good day, ladies and gentlemen and welcome to the Silence Therapeutics Interim Results 2 ...